Last $0.02 USD
Change Today +0.005 / 50.00%
Volume 28.8K
VIAP On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - via pharmaceuticals inc (VIAP)

Name (Connections)Board RelationshipsTitleKey Developments
Mark Bagnall CPA 29 RelationshipsIndependent Director, Chairman of Audit Committee, Co-Chairman of Compensation Committee and Member of Nominating & Governance Committee 
David Howard 45 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Co-Chairman of Compensation Committee and Member of Audit Committee 

Compensation Committee* - via pharmaceuticals inc (VIAP)

Name (Connections)Board RelationshipsTitle
Mark Bagnall CPA 29 RelationshipsIndependent Director, Chairman of Audit Committee, Co-Chairman of Compensation Committee and Member of Nominating & Governance Committee
David Howard 45 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Co-Chairman of Compensation Committee and Member of Audit Committee
VIAP Compensation vs. Industry
385.0K
364.8K
Chief Executive Officer
244.4K
273.5K
Chief Financial Officer
Share price activity for VIA PHARMACEUTICALS INC (VIAP)
52 Week Price Performance
VIAP
Industry Average

Nominating Committee* - via pharmaceuticals inc (VIAP)

Name (Connections)Board RelationshipsTitleKey Developments
Mark Bagnall CPA 29 RelationshipsIndependent Director, Chairman of Audit Committee, Co-Chairman of Compensation Committee and Member of Nominating & Governance CommitteeVIA Pharmaceuticals, Inc. Appoints Karen S. Wright as an Executive Officer
05/6/10
David Howard 45 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Co-Chairman of Compensation Committee and Member of Audit CommitteeVIA Pharmaceuticals, Inc. Announces the Demise of Richard L. Anderson, an Independent Director and A Member of Audit, Compensation, Nominating and Governance Committees
03/27/09

Corporate Governance Committee* - via pharmaceuticals inc (VIAP)

Name (Connections)Board RelationshipsTitle
Mark Bagnall CPA 29 RelationshipsIndependent Director, Chairman of Audit Committee, Co-Chairman of Compensation Committee and Member of Nominating & Governance Committee
David Howard 45 RelationshipsIndependent Director, Chairman of Nominating & Governance Committee, Co-Chairman of Compensation Committee and Member of Audit Committee
VIAP and Competitor
Insiders vs. External
Board
9%
91%
VIA Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - via pharmaceuticals inc (VIAP)

Name (Board Relationships)/Title Board Affiliations
Israel Charo 60 Relationships
Scientific Advisor
No other board affiliations
Marco Conti 21 Relationships
Scientific Advisor
No other board affiliations
Marcelo Di Carli 21 Relationships
Member of Clinical Advisory Board
No other board affiliations
Robert Fenichel 28 Relationships
Member of Clinical Advisory Board
No other board affiliations
Garret FitzGerald 41 Relationships
Scientific Advisor
No other board affiliations
Colin Funk 21 Relationships
Scientific Advisor
No other board affiliations
Christopher Glass 21 Relationships
Scientific Advisor
No other board affiliations
Tod Klingler 25 Relationships
Scientific Advisor
No other board affiliations
Peter Libby 43 Relationships
Member of Clinical Advisory Board
No other board affiliations
Donald Maurice 21 Relationships
Scientific Advisor
No other board affiliations
Marc Pfeffer 21 Relationships
Chair of Clinical Advisory Board
No other board affiliations
Thomas Quertermous 39 Relationships
Chief Scientific Officer and Member of Scientific Advisory Board
No other board affiliations
Paul Ridker 41 Relationships
Member of Advisory Board
No other board affiliations
Jean-Lucien Rouleau 26 Relationships
Member of Clinical Advisory Board
No other board affiliations
J. Tardif 59 Relationships
Member of Clinical Advisory Board
No other board affiliations
Renu Virmani 132 Relationships
Member of Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIAP:US $0.02 USD +0.005

VIAP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VIAP.
View Industry Companies
 

Industry Analysis

VIAP

Industry Average

Valuation VIAP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.